The global transcatheter embolization and occlusion devices market size is expected to reach USD 8.54 billion by 2030, registering a CAGR of 7.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. The global market is anticipated to register a strong CAGR of 9.7% from 2019 to 2026. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.
In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.
Asia Pacific TEO devices market is anticipated to witness highest CAGR from 2019 to 2026 due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices. Brazil was the highest revenue-generating country in Latin America in 2018. Improving healthcare services, growing medical tourism industry, and availability of regulatory framework in the country are further driving the market in Brazil
Request a free sample copy or view report summary: Transcatheter Embolization And Occlusion Devices Market Report
Coils accounted for the largest share. Availability of a broad range of coils in various shapes and sizes enables suitable product selection for different cases, making coiling a preferred treatment for embolization
Moreover, affordability of the commercially available devices spurs demand for coiling in occlusion
Accessories is expected to be the largest type segment due to wide usage of accessories across various modes of embolization and occlusion
North America along with Europe accounted for the largest share in 2022. Presence of advanced healthcare infrastructure, reimbursement coverage, and skilled professionals to perform procedures are some of the factors driving the growth of these regionsm
Moreover, quick adoption of advanced healthcare treatments and products coupled with the presence of well-defined regulatory framework are boosting North America and Europe markets
Grand View Research has segmented the transcatheter embolization and occlusion devices market based on product, application, and region:
Transcatheter Embolization And Occlusion Devices Devices Type Outlook (Revenue, USD Million, 2018 - 2030)
Coil
Pushable Coils
Detachable Coils
Non Coil
Flow Diverting Devices
Embolization Particles
Liquid Embolics
Other Embolization and Occlusion Devices
Others
Transcatheter Embolization And Occlusion Devices Devices Application Outlook (Revenue, USD Million, 2018 - 2030)
Peripheral Vascular Disease
Arterial Blockage
Venous Blood clot
Others
Oncology
Liver Cancer
Pancreatic Cancer
Breast Cancer
Kidney Cancer
Others
Neurology
Brain Aneurysm
Cerebral Arteriovenous Malformations
Others
Urology
Benign Prostatic Hyperplasia/Urinary Retention
Others (Varicocele)
Others
Transcatheter Embolization And Occlusion Devices Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List Of Key Players Transcatheter Embolization And Occlusion Devices Market
Boston Scientific Corporation
Terumo Corporation
Medtronic
DePuy Synthes
Stryker
Cordis
Abbott
Pfizer Inc.
Sirtex
Nordion
"The quality of research they have done for us has been excellent..."